{"id":"https://openalex.org/W3083661848","doi":"https://doi.org/10.1158/1538-7445.am2020-588","title":"Abstract 588: Characterization of oncolytic peptides for local bladder cancer therapy","display_name":"Abstract 588: Characterization of oncolytic peptides for local bladder cancer therapy","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083661848","doi":"https://doi.org/10.1158/1538-7445.am2020-588","mag":"3083661848"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-588","doi":"https://doi.org/10.1158/1538-7445.am2020-588","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-588","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082586785","display_name":"Amy Klova","orcid":"https://orcid.org/0000-0001-7606-9862","observed_orcids":["https://orcid.org/0000-0001-7606-9862"]},"institutions":[{"id":"https://openalex.org/I4405279837","display_name":"Ferring Research Institute (United States)","ror":"https://ror.org/02375gf80","country_code":"US","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4405279837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Klova","raw_affiliation_strings":["Ferring Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4405279837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037948005","display_name":"Hiroe Tariga","orcid":"https://orcid.org/0000-0003-1523-1074","observed_orcids":["https://orcid.org/0000-0003-1523-1074"]},"institutions":[{"id":"https://openalex.org/I4405279837","display_name":"Ferring Research Institute (United States)","ror":"https://ror.org/02375gf80","country_code":"US","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4405279837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hiroe Tariga","raw_affiliation_strings":["Ferring Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4405279837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100860230","display_name":"Suijin Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279837","display_name":"Ferring Research Institute (United States)","ror":"https://ror.org/02375gf80","country_code":"US","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4405279837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suijin Yang","raw_affiliation_strings":["Ferring Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4405279837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081236513","display_name":"Anastasia V. Velentza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279837","display_name":"Ferring Research Institute (United States)","ror":"https://ror.org/02375gf80","country_code":"US","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4405279837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anastasia Velentza","raw_affiliation_strings":["Ferring Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4405279837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043297813","display_name":"Jacek Stalewski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279837","display_name":"Ferring Research Institute (United States)","ror":"https://ror.org/02375gf80","country_code":"US","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4405279837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacek Stalewski","raw_affiliation_strings":["Ferring Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4405279837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088377829","display_name":"Adeela Kamal","orcid":"https://orcid.org/0009-0000-0300-4961","observed_orcids":["https://orcid.org/0009-0000-0300-4961"]},"institutions":[{"id":"https://openalex.org/I4405279837","display_name":"Ferring Research Institute (United States)","ror":"https://ror.org/02375gf80","country_code":"US","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4405279837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adeela Kamal","raw_affiliation_strings":["Ferring Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4405279837"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038508128","display_name":"Scott R. P. McDonnell","orcid":"https://orcid.org/0000-0003-3127-7101","observed_orcids":["https://orcid.org/0000-0003-3127-7101"]},"institutions":[{"id":"https://openalex.org/I4405279837","display_name":"Ferring Research Institute (United States)","ror":"https://ror.org/02375gf80","country_code":"US","type":"company","lineage":["https://openalex.org/I22138158","https://openalex.org/I4405279837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott McDonnell","raw_affiliation_strings":["Ferring Research Institute, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ferring Research Institute, San Diego, CA","institution_ids":["https://openalex.org/I4405279837"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405279837"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"588","last_page":"588"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.12720000743865967,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-peptide","display_name":"oncolytic peptide","score":0.9399999976158142},{"id":"https://openalex.org/keywords/antimicrobial-peptides","display_name":"antimicrobial peptides","score":0.9909999966621399},{"id":"https://openalex.org/keywords/non-muscle-invasive-bladder-cancer","display_name":"non-muscle-invasive bladder cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/intravesical-therapy","display_name":"intravesical therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/temporin-l","display_name":"temporin L","score":0.9800000190734863},{"id":"https://openalex.org/keywords/t24-cells","display_name":"T24 cells","score":0.7350000143051147},{"id":"https://openalex.org/keywords/urothelial-cells","display_name":"urothelial cells","score":0.847000002861023},{"id":"https://openalex.org/keywords/cell-death-kinetics","display_name":"cell death kinetics","score":0.8560000061988831},{"id":"https://openalex.org/keywords/washout","display_name":"washout","score":0.46700000762939453},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.7419999837875366},{"id":"https://openalex.org/keywords/peptide-screening","display_name":"peptide screening","score":0.4129999876022339},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.6549999713897705},{"id":"https://openalex.org/keywords/bladder-cancer-recurrence","display_name":"bladder cancer recurrence","score":0.5600000023841858},{"id":"https://openalex.org/keywords/temporal-selectivity","display_name":"temporal selectivity","score":0.546999990940094},{"id":"https://openalex.org/keywords/necrosis","display_name":"necrosis","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.8949924111366272},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.7775943875312805},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.621578574180603},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5813592672348022},{"id":"https://openalex.org/C31695470","wikidata":"https://www.wikidata.org/wiki/Q11293125","display_name":"Organoid","level":2,"score":0.5273776054382324},{"id":"https://openalex.org/C2777283488","wikidata":"https://www.wikidata.org/wiki/Q7095181","display_name":"Oncolytic adenovirus","level":4,"score":0.5201737880706787},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4907001256942749},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.46494853496551514},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4438958466053009},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.429575651884079},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40298348665237427},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24704742431640625},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-588","doi":"https://doi.org/10.1158/1538-7445.am2020-588","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-588","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2058963522","https://openalex.org/W2060885550","https://openalex.org/W7095354429","https://openalex.org/W3011172061","https://openalex.org/W2130592961","https://openalex.org/W7125712680","https://openalex.org/W2810600065","https://openalex.org/W4297920270","https://openalex.org/W3196444751","https://openalex.org/W2135081205"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Bladder":[2,170],"cancer":[3,9,45,171,215,318,335,408],"is":[4,313],"the":[5,11,78,115,123,227,254,266,273,286,294,302,351,376,414,418],"sixth":[6],"most":[7,295],"common":[8],"in":[10,89,150,212,245,344,368],"United":[12],"States,":[13],"with":[14,40,188,281,320],"over":[15,359],"80,000":[16],"new":[17],"cases":[18],"diagnosed":[19,39],"each":[20],"year.":[21],"While":[22,80,251],"patients":[23,38],"often":[24],"initially":[25],"respond":[26],"positively":[27],"to":[28,138,271,355,375,378],"treatment,":[29],"it":[30,354],"has":[31],"been":[32,84],"found":[33],"that":[34,69,291,311],"nearly":[35],"75%":[36],"of":[37,108,125,133,205,229,259,268,275,298,301,315,332,347,383,402,413,417],"high-grade":[41],"non-muscle":[42],"invasive":[43],"bladder":[44,214,334,407],"(NMIBC)":[46],"will":[47],"develop":[48],"a":[49,203,321],"recurrence":[50],"within":[51,285],"ten":[52],"years.":[53],"Treatment":[54],"options":[55],"for":[56,86,111,209,238,353,372,405,421],"recurrent":[57],"NMIBC":[58,112,373],"are":[59,65],"severely":[60],"lacking.":[61],"Antimicrobial":[62],"peptides":[63,110,144,330,404],"(AMPs)":[64],"naturally":[66],"occurring":[67],"molecules":[68,82,277],"kill":[70],"bacteria":[71],"by":[72,118],"forming":[73],"membrane":[74],"pores":[75],"and":[76,97,141,145,158,167,183,195,236,350,381,428],"lysing":[77],"cells.":[79,336,361],"these":[81,276,338],"have":[83,101],"explored":[85],"their":[87,94,147],"use":[88],"oncology":[90],"as":[91,217,219,278],"oncolytic":[92,109,143,329,403],"peptides,":[93,339],"low":[95],"potency":[96],"limited":[98],"therapeutic":[99],"index":[100],"hindered":[102],"further":[103,239,264],"development.":[104],"However,":[105],"intravesical":[106,279,370],"delivery":[107],"could":[113],"minimize":[114],"current":[116],"issues":[117],"enabling":[119],"high":[120],"concentrations":[121],"at":[122],"site":[124],"action":[126],"while":[127],"limiting":[128],"systemic":[129],"exposure.":[130,384],"The":[131],"aim":[132],"this":[134,230],"research":[135],"project":[136],"was":[137,289],"identify":[139],"potent":[140],"selective":[142],"investigate":[146],"functional":[148],"activity":[149,211],"vitro.":[151],"Methods:":[152],"T24":[153,213],"(bladder":[154],"transitional":[155],"cell":[156,269,299,348],"carcinoma)":[157],"HUC":[159],"(normal":[160],"urothelial":[161,222],"cells)":[162],"were":[163,174,186,234,243],"purchased":[164],"from":[165,176,253],"ATCC":[166],"ScienCell,":[168],"respectively.":[169],"organoid":[172,249],"models":[173],"acquired":[175],"Dr.":[177],"Shen's":[178],"laboratory":[179],"(Columbia":[180],"University).":[181],"Proliferation":[182],"cytotoxicity":[184],"measurements":[185],"conducted":[187],"alamarBlue":[189],"(Thermo":[190],"Fisher),":[191],"CellTiter-Glo":[192],"3D":[193],"(Promega)":[194],"xCELLigence":[196],"RTCA":[197],"(ACEA":[198],"Biosciences).":[199],"Results:":[200],"We":[201,325],"screened":[202],"library":[204],"~40":[206],"known":[207],"AMPs":[208],"antiproliferative":[210],"cells,":[216],"well":[218],"normal":[220,360],"human":[221],"cells":[223,319],"(HUCs).":[224],"Based":[225],"on":[226],"results":[228,252],"experiment,":[231],"six":[232,303],"hits":[233,242,305],"identified":[235,326],"selected":[237],"characterization.":[240],"These":[241,362],"validated":[244],"two":[246],"patient":[247],"derived":[248],"models.":[250],"phenotypic":[255],"screen":[256],"showed":[257],"lack":[258],"selectivity":[260,358],"against":[261],"HUCs,":[262],"we":[263],"investigated":[265],"kinetics":[267,297,346],"death":[270,300,349],"determine":[272],"utility":[274],"therapies":[280],"short":[282],"residence":[283],"time":[284],"bladder.":[287],"It":[288],"determined":[290],"Temporin-L":[292,312,340],"exhibited":[293,341],"rapid":[296],"peptide":[304],"analyzed.":[306],"Furthermore,":[307],"washout":[308],"studies":[309],"revealed":[310],"capable":[314,331],"quickly":[316],"killing":[317,333],"lasting":[322],"effect.":[323],"Conclusion:":[324],"several":[327],"reference":[328],"Of":[337],"unique":[342,363],"characteristics":[343],"its":[345],"potential":[352],"provide":[356],"temporal":[357],"properties":[364],"may":[365],"be":[366],"advantageous":[367],"local":[369,406],"therapy":[371,409],"due":[374],"availability":[377],"control":[379],"concentration":[380],"duration":[382],"Citation":[385],"Format:":[386],"Amy":[387],"Klova,":[388],"Hiroe":[389],"Tariga,":[390],"Suijin":[391],"Yang,":[392],"Anastasia":[393],"Velentza,":[394],"Jacek":[395],"Stalewski,":[396],"Adeela":[397],"Kamal,":[398],"Scott":[399],"McDonnell.":[400],"Characterization":[401],"[abstract].":[410],"In:":[411],"Proceedings":[412],"Annual":[415],"Meeting":[416],"American":[419],"Association":[420],"Cancer":[422,434],"Research":[423],"2020;":[424],"2020":[425],"Apr":[426],"27-28":[427],"Jun":[429],"22-24.":[430],"Philadelphia":[431],"(PA):":[432],"AACR;":[433],"Res":[435],"2020;80(16":[436],"Suppl):Abstract":[437],"nr":[438],"588.":[439]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-09-11T00:00:00"}